Skip to content
Abierto
Menu

Award notice

Pegfilgrastim 6MG/.06ML with VMI

75A50324R00004

Office of Assistant Secretary for Preparedness and Response, Aspr/Orm-Sns. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Coherus Oncology, Inc.

$45,162,200.00 on the award notice, March 19, 2025, contract 75A50325C00002

Description

As published on SAM.gov.

This requirement is for the procurement of Pegfilgrastim 6MG/.06ML injection solution in syringe or autoinjector format (INJ, SOLN, SYR, or Autoinjector) with the FDA approved indication for treatment of hematopoietic subsyndrome of acute radiation syndrome, and Vendor Managed Inventory (VMI) services.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Coherus Oncology, Inc.
UEI
V13JDMAMELK8
CAGE
88J79
Vendor location
Redwood City, CA
Contract
75A50325C00002, definitive contract
Obligated
$19,420,700.00, potential $45,162,200
Actions
3 between March 19, 2025 and March 18, 2026
Competition
Full and Open Competition, 4 offers received
Set-aside reported
No Set Aside Used.
Described as
Pegfilgrastim 6mg/.06ml (Inj, Soln, Syr or Autoinjector) and Vmi
Match
award number 75A50325C00002 equals the contract number; same awarding office 75A503 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. March 20, 2025

    Award notice, originally combined synopsis and solicitation

    Awarded to COHERUS BIOSCIENCES, Inc. Redwood City for $45,162,200. SAM.gov, notice 12b3e638abf9494bafecf358427137ec

Points of contact

Also open from this buyer